Ani Pharmaceuticals reported $418.86M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 190.63B 8.32B
Aerie Pharmaceuticals AERI:US $ 538.46M 212.3M
Ani Pharmaceuticals ANIP:US $ 418.86M 27.67M
Aurora Cannabis Inc ACB:CN 1.74B 487.13M
Biodelivery Sciences International BDSI:US $ 355.94M 3.2M
Canopy Growth Corp WEED:CN C$ 6.9B 4.85B
Depomed DEPO:US $ 40.31M 29.1M
Eli Lilly And LLY:US $ 221.02B 902.49M
Emergent Biosolutions EBS:US $ 2.69B 686.55M
Endo International Ordinary Shares ENDP:US 756.54M 335.33M
Flexion Therapeutics FLXN:US $ 306.78M 104.24M
Heron Therapeutics HRTX:US $ 1.09B 490.97M
Hikma Pharmaceutical HIK:LN 5.66B 142.14M
Knight Therapeutics Inc GUD:CN C$ 672.31M 10.75M
Lannett LCI:US $ 126.83M 66.72M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Novartis NVS:US 200.79B 24.12B
Omeros OMER:US $ 861.81M 63.14M
Perrigo Ordinary Shares PRGO:US 6.33B 205.5M
Sun Pharmaceuticals SUNP:IN 1963.26B 342.63B
Teva Pharmaceutical TEVA:IT 34.99B 801.25M
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M